Search

Your search keyword '"Held, G"' showing total 850 results

Search Constraints

Start Over You searched for: Author "Held, G" Remove constraint Author: "Held, G"
850 results on '"Held, G"'

Search Results

1. Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial

6. Insights into the High Activity of Ruthenium Phosphide for the Production of Hydrogen in Proton Exchange Membrane Water Electrolyzers

7. Therapie bösartiger Hämoblastosen mit monoklonalen Antikörpern

8. Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

13. DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia

14. RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features

16. P545: CHARACTERISTICS AND OUTCOME OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND TRISOMY 19

17. S101: GENETIC AND EPIGENETIC FACTORS DRIVING PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATHOGENESIS AND OUTCOME

24. Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group

26. Resonant X-ray photoelectron spectroscopy: identification of atomic contributions to valence states

30. SPARC-positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double-/triple-hit status

37. Analysis of a safety run-in cohort from NIVEAU, a phase 3 study for patients with aggressive Non-Hodgkin lymphoma in first relapse or progression not eligible for High-Dose Chemotherapy (HDT) testing Nivolumab in combination with (R)-GemOx

38. FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : results from the prospective, multicenter PETAL and OPTIMAL > 60 trials

42. Role of radiotherapy and dose-densification of R-CHOP in primary mediastinal B-cell lymphoma: a subgroup analysis of the unfolder trial of the German Lymphoma Alliance (GLA)

43. 10-year follow-up of the R-MegaCHOEP trial: conditional survival analysis reveals 1-year progression-free survival as crucial prognostic factor for long-term outcome in young high-risk patients with aggressive B-cell lymphoma

46. Effect of oxygen adsorption on the chiral Pt{531} surface

Catalog

Books, media, physical & digital resources